NURR1 TRANSCRIPTION FACTOR IBOX MUTANTS HAVING MONOMERIC TRANSCRIPTIONAL ACTIVATION ACTIVITY

Details for Australian Patent Application No. 2002249140 (hide)

Owner LUDWIG INSTITUTE FOR CANCER RESEARCH

Inventors PERLMANN, Thomas; AARNISALO, Piia

Pub. Number AU-A-2002249140

PCT Pub. Number WO2002/059303

Priority 0102087.4 26.01.01 GB

Filing date 25 January 2002

Wipo publication date 6 August 2002

International Classifications

C12N 015/12 Mutation or genetic engineering - Genes encoding animal proteins

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C12N 015/63 Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C07K 014/705 Peptides having more than 20 amino acids

Event Publications

6 February 2003 Application Open to Public Inspection

  Published as AU-A-2002249140

12 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002249141-ISOLATION OF NANOPARTICLES

2002249139-PESTICIDAL FORMULATION